Geron Corp (NASDAQ:GERN)
| 1.86 Delayed Data As of May 22 |  -0.10 / -5.10%Today’s Change | 0.75 Today|||52-Week Range 2.40 | +36.76% Year-to-Date |
Latest GERN News | Press Releases
| Why Geron Stock Soared 23.4% Today May 15 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.96 |
| Today’s open | 1.42 |
| Day’s range | 1.40 - 1.88 |
| Volume | 1,111,664 |
| Average volume (3 months) | 2,021,529 |
| Market cap | $372.7M |
Data as of 4:52pm ET, 05/22/2020
Growth & Valuation
| Earnings growth (last year) | -135.47% |
| Earnings growth (this year) | -21.67% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -56.85% |
| P/E ratio | NM |
| Price/Sales | 562.21 |
| Price/Book | 2.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| UBXUNITY Biotechnology ... | +0.15 | +2.10% |
| MGTAMagenta Therapeutics... | +0.11 | +1.15% |
| DTILPrecision BioScience... | -0.38 | -4.92% |
| KMDAKamada Ltd | +0.22 | +2.63% |
Data as of 3:59pm ET, 05/22/2020
Financials
| Last reporting date | May 22, 2020 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $460.0K |
| Annual profit (last year) | -$68.5M |
| Net profit margin | -14,901.74% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
